Skip to content

NTHI NTHI Free cash flow yield

Free cash flow yield at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
9.6%-0.9pp
Pfizer logo
PfizerPFE
7.8%+4.6pp
Merck & Co. logo
Merck & Co.MRK
4.7%-2.8pp
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-7.8%-3.3pp
Nuvation Bio logo
Nuvation BioNUVB
-9%-3.6pp
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-11%+4.2pp

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Operating income-$7.1M+77.9%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K
Total equity-$13.2M-37.5%
Total assets$3.3M-60.6%

Cash flow

See full
Operating cash flow-$7.0M-23.7%
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%
P/S1,432.9×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%
FCF margin-26,083.2%

Returns & leverage

See full
Return on equity338.1%
Debt / equity-0.1×
Current ratio0.1×-0.3×

Where this comes from

Calculated from NTHI’s reported figures.

Based on trailing twelve months.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NTHI's free cash flow yield?
NTHI (NTHI) reported free cash flow yield of -10.5% in Q4 2025.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.